Insulin

Do sugar substitutes really help? New research reveals their impact on metabolism and gut health

by

Unraveling the Sweet Future of Sugar Substitutes Conquering the Calorie Conundrum With obesity and diabetes rates on the rise globally, sugar substitutes are becoming increasingly popular. The average person consumes far more than the recommended sugar intake, leading to significant health risks. Low and no-calorie sweeteners (LNCSs) offer a promising solution to this issue by … Read more

Water-only fasting boosts human growth hormone without weight loss

by

Unlocking the Health Potential of Fasting As research delves deeper into human health and longevity, fasting emerges as a promising avenue for enhancing well-being. A recent study published in Frontiers in Endocrinology shows how a simple 24-hour water fast can significantly boost HGH levels, especially for those with lower baseline levels. This finding challenges conventional … Read more

Vitamin E significantly improves liver health in MASH patients, new study finds

by

The Promising Future of Vitamin E in Liver Health Recent research has illuminated the potential of Vitamin E as a transformative treatment for Metabolic Dysfunction-Associated Steatohepatitis (MASH). A robust study published in Cell Reports Medicine highlighted significant improvements in liver histology and reduced inflammatory markers among participants who received a daily dose of 300 mg … Read more

Exercise improves brain insulin sensitivity and lowers dementia risk in older adults with prediabetes

by

Exercise and Cognitive Health: Harnessing the Brain’s Insulin Pathway Recent findings in the publication Aging Cell indicate that a two-week exercise regimen may enhance insulin signaling in the brain—a promising stride in managing prediabetes and potentially reducing Alzheimer’s and other dementia risks. These insights spotlight the intricate interplay between the brain’s insulin pathways and exercise, … Read more

GLP1RA medications linked to behavioral side effects in type 2 diabetes and obesity

by

The Evolving Role of GLP1RA in Diabetes Management and Mental Health As the use of GLP1RA—glucagon-like peptide 1 receptor agonists—grows in managing type 2 diabetes and obesity, there is increasing interest in their behavioral side effects. Recent research published in Diabetes, Obesity and Metabolism offers an in-depth look at these potential side effects and offers … Read more

© 2026 Newsy Today. All rights reserved.


For contact, advertising, copyright, issues email: office@newsy-today.com

For contact, advertising, copyright, issues email: office@newsy-today.com